IDH1 mutations in gliomas: First series from a tertiary care centre in India with comprehensive review of literature-Reference-Cited by-同舟云学术

IDH1 mutations in gliomas: First series from a tertiary care centre in India with comprehensive review of literature

Published:2011-08 Issue:1 Volume:91 Page:385-393
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Jha Prerana,Suri Vaishali,Sharma Vikas,Singh Geetika,Sharma Mehar Chand,Pathak Pankaj,Chosdol Kunzang,Jha Pankaj,Suri Ashish,Mahapatra Ashok Kumar,Kale Shashank Sharad,Sarkar Chitra

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference31 articles.

1. Analysis of the IDH1 codon 132 mutation in brain tumors;Balss;Acta Neuropathol.,2008

2. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors;Bleeker;Hum. Mutat.,2009

3. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors;Capper;Brain Pathol.,2010

4. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate;Dang;Nature,2009

5. IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide;Dubbink;Neurology,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Evaluation of Diffuse Gliomas Using IDH1 and ATRX in a Resource-Limited Setting;Cureus;2024-07-27

2. Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population;Cureus;2022-06-29

3. Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors;Indian Journal of Neurosurgery;2022-06-08

4. Analysis of Isocitrate dehydrogenase (IDH) mutation in Gliomas---a call for neurosurgeons and pathologists in Pakistan;Journal of the Pakistan Medical Association;2022-05-07

5. Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center;JCO Global Oncology;2022-05